Growth Hormone in Ischemic Heart Failure

PHASE3CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

April 28, 2004

Primary Completion Date

February 25, 2012

Study Completion Date

February 25, 2012

Conditions
Heart Failure, SystolicIschemic Heart Disease Chronic
Interventions
DRUG

Somatropin

Dose: 1,4 mg (4,2 IE) every other day Dosage: 9 month treatment period and a 3 month follow-up period Administration: One subcutaneous injection of somatropin or corresponding placebo in the thigh or abdomen given in the evening given every other day.

DRUG

Placebo

Placebo

All Listed Sponsors
lead

Göteborg University

OTHER

NCT04420481 - Growth Hormone in Ischemic Heart Failure | Biotech Hunter | Biotech Hunter